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Abstract
Background: The use of process evaluations is a growing area of interest in research groups working on complex
interventions. This methodology tries to understand how the intervention was implemented to inform policy and
practice. A recent systematic review by Liu et al. on process evaluations of complex interventions addressing non-
communicable diseases found few studies in low- and middle- income countries (LMIC) because it was restricted to
randomized controlled trials, primary healthcare level and non-communicable diseases. Yet, LMICs face different
barriers to implement interventions in comparison to high-income countries such as limited human resources,
access to health care and skills of health workers to treat chronic conditions especially at primary health care level.
Therefore, understanding the challenges of interventions for non-communicable diseases and neglected tropical
diseases (diseases that affect poor populations and have chronic sequelae) will be important to improve how
process evaluation is designed, conducted and used in research projects in LMICs. For these reasons, in comparison
to the study of Liu et al., the current study will expand the search strategy to include different study designs,
languages and settings.
Objective: Map research using process evaluation in the areas of non-communicable diseases and neglected
tropical diseases to inform the gaps in the design and conduct of this type of research in LMICs.
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Methods: Scoping review of process evaluation studies of randomized controlled trials (RCTs) and non-RCTs of
complex interventions implemented in LMICs including participants with non-communicable diseases or neglected
tropical diseases and their health care providers (physicians, nurses, technicians and others) related to achieve
better health for all through reforms in universal coverage, public policy, service delivery and leadership. The
aspects that will be evaluated are as follows: (i) available evidence of process evaluation in the areas of non-
communicable diseases and neglected tropical diseases such as frameworks and theories, (ii) methods applied to
conduct process evaluations and (iii) gaps between the design of the intervention and its implementation that
were identified through the process evaluation. Studies published from January 2008. Exclusion criteria are as
follows: not peer reviewed articles, not a report based on empirical research, not reported in English or Spanish or
Portuguese or French, reviews and non-human research.
Discussion: This scoping review will map the evidence of process evaluations conducted in LMICs. It will also
identify the methods they used to collect and interpret data, how different theories and frameworks were used and
lessons from the implementation of complex interventions. This information will allow researchers to conduct
better process evaluations considering special characteristics from countries with limited human resources, scarce
data available and limited access to health care.
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Background
Why is this field of research important?
According to the Medical Research Council guide-
lines, a process evaluation is “a study which aims to
understand the functioning of an intervention needed
to inform policy and practice, by examining three
areas: (i) Implementation: resources and processes
through which the intervention delivery is achieved,
and the quantity and quality of what is delivered of
the planned intervention; (ii) Mechanisms of impact:
how intervention activities, and participants’ interac-
tions, trigger change; (iii) Context: how external fac-
tors influence the delivery and functioning of
interventions [1]”. It is important to mention that
process evaluation is complementary to, but not a
substitute for high quality outcomes evaluation. Also,
process evaluations can be conducted at different mo-
ments in the pathway of a project with different ob-
jectives like feasibility phases to inform the future
development of a randomized controlled trial, evalua-
tions of effectiveness to inform the scale-up process
or post-evaluation scale-up to evaluate the sustainabil-
ity of the intervention [1].
Recently process evaluation has been gaining traction
because of the growing implementation of complex in-
terventions. This type of intervention usually has many
actors and components that interact between them [2]
and may include a logic model where the programme
theory was fully articulated. For these reasons, it is im-
portant to understand how the different intervention
components are implemented and explore the interac-
tions between them focusing on the value of under-
standing context and mechanisms to inform scale and
spread of complex interventions.
What is known about this field currently?
A previous systematic review of process evaluations of
primary health care interventions worldwide addressing
non-communicable diseases (NCD) was conducted by
Liu et al. [3]. The study included 69 studies (25 studies
in cardiovascular diseases, 20 in depression, 17 in dia-
betes, 6 in chronic obstructive pulmonary disease and 1
in chronic kidney disease). Only 22 studies were labelled
as process evaluation, whereas the other studies had as
their aim to understand the functioning of the interven-
tion to inform policy and practice or evaluated at least
one of the three areas of process evaluation (implemen-
tation, mechanisms of impact or context).
The main strengths of the studies were the justifica-
tion of the choice of their methods, robust sampling
strategies and the use of qualitative and quantitative data
triangulated to understand mechanisms of implementa-
tion. Also, the strength of 22 studies was the use of
existing theories and/or frameworks to inform their
intervention development and/or evaluation, whereas in
fourteen papers, the interaction of the intervention and
contextual factors were explicitly explored.
On the other hand, the main limitations were that
there was an overall lack of consistency in how process
evaluation were conducted and reported. Thirty-five
studies stated clearly the separation between the process
and the outcome evaluation and only 30 studies of the
69 had a clear intervention description and clarification
of causal assumptions [4].
The limitations found in the results of the process
evaluation of the complex interventions were principally:
(i) the lack of alignment between local needs expressed
by stakeholders and the intervention, (ii) the under-
standing of roles and responsibilities of key stakeholders
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responsible to implement the intervention and (iii) the
knowledge of the health system structure—factors such
as governance, financing structures and workforce—that
could affect the implementation of the intervention [4].
Why a scoping review?
A scoping review is an approach to scan the literature
broadly, determine scope of evidence in a field and key
elements associated with that evidence. The approach is
aligned with the aim of identifying available evidence in
a given field, clarifying concepts/definitions in the litera-
ture, examining how research is conducted on a certain
topic or field, identifying key characteristics or factors
related to a concept and identifying and analysing know-
ledge gaps [5, 6].
Why do this review?
Process evaluation is a growing area of interest in re-
search groups that work in the design and implementa-
tion of complex interventions. Low- and middle-income
countries (LMIC) face different barriers to implement
interventions in comparison to high-income countries
such as limited human resources, limited access to
health care and limited skills of health workers to treat
non-communicable diseases especially at primary health
care level [7]. Liu et al. [4] found limited information
about process evaluations for NCDs in LMICs (1 study
in India, 1 in Malaysia and 1 in Zambia). One of the rea-
sons for this was that this review only included random-
ized controlled trials, at primary healthcare level, on
NCDs, and studies published in English. In addition,
guidance to date to conduct process evaluation has been
developed in high-income countries with little LMIC in-
put [1]. Learning from previous experiences will be im-
portant to improve how process evaluation is designed,
conducted and used in research projects in LMICs and
this potentially could inform the future scaling-up of
interventions.
This scoping review is conducted by researchers who
work mostly in LMICs in primary health care and hos-
pital settings to address NCDs. Several authors are part
of the COHESION project [8] which looks at addressing
health challenges faced in LMICs related to neglected
tropical diseases (NTDs) and NCDs. The main objective
of the COHESION project is “that sustainable, gender
and context appropriate interventions at policy, health
system, and community level can be developed and inte-
grated into Primary Health Care responses once there is
a clear understanding of barriers and enablers of the
diagnosis, management and care of NCDs and NTDs at
each level.” [8] NCDs has a growing impact in LMICs
with variability in terms of burden and mortality be-
tween and within those countries [9–11]. NTDs affect
the more vulnerable population worldwide with poor
access to healthcare services [12, 13]. Looking at NCDs
and NTDs shows at different levels a co-existence, (i) in-
dividual level: a double burden of disease in the same
patient [14, 15], (ii) community level: the population af-
fected by these conditions co-exist in low-income set-
tings and (iii) health system level: explore how the
health system response to chronic conditions in LMICs
[9, 16, 17].
General objective
 Map the research on process evaluation in the areas
of NCDs and NTDs to inform the gaps in the design
and conduct of this type of research in LMIC.
Specific objectives
 Determine how many studies are labelled as process
evaluation and identify other terms used instead of
process evaluation in the literature.
 Examine how research in process evaluation studies
is designed and conducted (which methods are
used—quantitative, qualitative and mixed
methods—and in which moment during the
project—feasibility testing phases, alongside
evaluations of effectiveness, or alongside post-
evaluation scale-up-) in LMICs
 Identify key theories related to process evaluation
use by researchers in LMICs
 Identify and analyse strengths and weaknesses of the
process evaluation design in LMICs
Methods
This protocol will use the following: the PRISMA guidelines
for reporting systematic reviews and meta-analysis protocol
[18], the methodological guidance of Arksey et al. [19] and
Levac et al. [20] and for the final report of the results, the
PRISMA extension for scoping reviews [21].
Eligibility criteria
Type of studies: Process evaluation of randomized con-
trolled trials (RCTs) and non-RCTs (feasibility studies,
observational studies, quasi experimental studies). Given
that process evaluations are often not explicitly labelled
as such, we will include studies with the stated aim of
understanding the functioning of an intervention to in-
form policy and practice and which evaluated at least
one of the three areas (implementation, mechanisms of
impact or context).
Participants: Patients with NCDs (type 2 diabetes mellitus,
type 1 diabetes mellitus, cardiovascular disease, depression,
chronic obstructive pulmonary disease and chronic kidney
disease) [22] and NTDs (Buruli ulcer, Chagas disease, dengue
and chikungunya, dracunculiasis-guinea worm diseases,
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echinococcosis, foodborne trematodiases, human African
trypanosomiasis-sleeping sickness, leishmaniasis, leprosy-
Hansen’s diseases, lymphatic filariasis, onchocerciasis-river
blindness, rabies, schistosomiasis, soil-transmitted helminthi-
ases, taeniasis/cysticercosis, trachoma, yaws-endemic trepo-
nematoses, chromoblastomycosis and other deep mycoses,
scabies and other ectoparasites and snakebite envenoming)
[23], and/or their health care providers (physicians, nurses,
technicians, and others related to achieve better health).
Intervention: Complex interventions “interventions
that comprise multiple interacting components, although
additional dimensions of complexity include the diffi-
culty of their implementation and the number of
organizational levels they target” [2]. The setting of the
intervention considered will be at community, health
system or policy level. These include community, pri-
mary health care and hospital level interventions, but
also those related to reforms in universal coverage, pub-
lic policy, service delivery and leadership.
Comparator: The control condition could be absent
(e.g. pre-post evaluations) or may include treatment as
usual, active control or placebo control. Also, studies
with multiple active interventions will be included.
Timing: Published data from January 2008, this date
was selected because in that year the Medical Research
Council updated their guidance for developing and
evaluating complex interventions [2].
Setting: LMIC according to The World Bank in 2019,
which included 31 low-income economies, 47 lower–
middle-income economies and 60 upper–middle-income
economies [24].
Exclusion criteria: not a peer reviewed article, not a re-
port based on empirical research, not reported in Eng-
lish or Spanish or Portuguese or French, reviews and not
human research.
Information sources
PubMed, EbscoHost, Web of Science (WOS), Virtual Health
Library (VHL) regional Portal and Global Index Medicus:
Regional Indexes AIM (AFRO), LILACS (AMRO/PAHO),
IMEMR (EMRO), IMSEAR (SEARO), WPRIM (WPRO)
Global Index Regional Indexes, MEDLINE, SciELO. A differ-
ent search strategy will be designed for each database.
Search strategy
Search strategy will be developed to capture relevant
studies in multiple relevant electronic databases (detailed




Covidence (Veritas Health Innovation Ltd), a Cochrane
technology platform, will be used to the screening
process. Citations will be imported from the databases,
titles and abstracts will be screened, then manuscripts
will be selected to proceed to data extraction.
Selection process
Two reviewers will independently consider the potential
eligibility of each of the abstracts and titles that result
from executing the search strategy. Reviewers will re-
quest the full text versions of all potentially eligible stud-
ies. Disagreements will be solved by a third reviewer.
Two reviewers working independently and blindly will
consider the full text reports (all available versions of
each study) for eligibility (Supplementary Material 2).
We will conduct a calibration exercise at the stage of
titles and abstract screening. Meetings will be held to
discuss the inclusion and exclusion criteria and later to
contrast our decisions to include or exclude some arti-
cles to the next stage. During full-text screening, the all
team will have two meetings to solve conflicts and then
in pairs we will solve our conflicts together every 3
weeks. We did not consider a level of agreement to
move forward, but the level of agreement will be
reported.
Data collection process and data items
Data extraction will include (i) full description of study and
the complex intervention, i.e. type of study, participants en-
rolled, the interventions they received, causal assumptions
(hypothesis of how the intervention would work), setting,
type of disease (NCD or NTD), specific framework and/or
theory of the intervention (If YES, please specify which
framework and/or theory), specific disease, main trial out-
come (positive/negative/ equivalent). The following will also
be explored (ii) details about the process evaluation if it is
clearly labelled as a process evaluation, objective, pre-
specified protocol, stage when the process evaluation was ap-
plied, specific framework and/or theory of the process evalu-
ation (If YES, please specify which framework and/or theory,
adaptations of framework and/or theory; and how the frame-
work and/or theory of the Process Evaluation was used),
method used, leading team of the evaluation (dependent or
independent of the research team) and type of analysis
(quantitative, qualitative, both); (iii) lessons learned about the
process evaluation: strengthens and weaknesses of the design
of the process evaluation and barriers and facilitators for im-
plementation of complex interventions. The tools can be
found in Supplementary Material 3, and these are a modified
version of those used by Liu et al. [3]. Additionally, how the
information of the process evaluation was used will be col-
lected (e.g. is the information of the process evaluation was
used to inform future RCTs or future scale up at regional or
national level or to improve the implementation pro-
grammes). Gaps detected by the process evaluation related
to the implementation of the intervention (the difference
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between what was planned in theory and what was actually
implement) will be identified, but also recognize when the
intervention was implemented as planned.
The extraction format will be piloted by two re-
searchers with 5 studies of different conditions (NCDs.
NTDs) and different study types (RCTs and non-RCTs).
Then, data will be extracted individually.
Evaluation
Aspects that will be evaluated are:
(1) Available evidence in process evaluation in the
areas of NCDs and NTDs like frameworks and
theories
(2) Methods applied to conduct process evaluations
(3) The stated strengths and weakness of the process
evaluation methodology from the perspectives of
the authors and scoping review researchers.
(4) Information on if the intervention was implemented
as planned as well as gaps identified by the process
evaluation between the design of the intervention
and its implementation.
(5) Findings from the process evaluations related to
barriers and facilitators of implementation of the
complex intervention.
This scoping review will use the Medical Research
Council framework, and this will be used as the data ex-
traction template as well as to report our results. In-
cluded studies will be compared with some parameters
of the Medical Research Council Guidance: if the study
was labelled as process evaluation; which type of
methods were used; how many studies considered con-
text, mechanism of action and implementation out-
comes; and how many studies included theories or
frameworks as well as report how they use its theories
or frameworks (process evaluation was informed by the-
ory, applied theory or tested theory) [25].
The information will be synthesized through quantita-
tive and qualitative analysis. Most variables will be ex-
tracted using codes, e.g. data related to the methods of
the process evaluation and details of the intervention;
whereas other variables like strengths and weakness, fa-
cilitators and barriers and how the information of the
process evaluation was used will be literally extracted,
and then codes will be generated to synthesize and
organize the information.
Discussion
This scoping review will allow for a better understanding
of the use of process evaluations conducted in LMICs. It
will also identify the methods they used to collect and
interpret data, how different theories and frameworks
were used and adapted, lessons on the strengths and
weakness of process evaluations, as well as identifying
barriers and/or facilitators from the implementation of
complex interventions in LMICs. This information will
allow researchers to conduct better process evaluations
considering special characteristics from countries with
limited human resources [26], scarce data available [27,
28] and limited access to health care [29].
Implementation science research, especially as related
to process evaluation in LMICs, faces many challenges
in comparison to high-income countries. First, barriers
in implementing complex interventions in LMIC are
related to limited resources to conduct research. For ex-
ample, in high-income countries, it is possible to con-
duct process evaluation with rich data collection
through electronic medical records [30], whereas in poor
resources settings, decisions need to be made on which
aspect of the process is most essential to focus on.
Therefore, this review could be the starting point to in-
form how we could be more efficient and effective and
conduct a targeted process evaluation that can address
major areas of uncertainty, within limited resources, and
not attempt to cover all questions. Second, the limited
resources in the health system and in the context of
complex interventions implemented in LMICs will en-
counter different barriers and facilitators and this scop-
ing review will identify them and inform future research
in NCDs and NTDs in those settings.
Another important aspect of this scoping review is the
focus on chronicity, given the focus on NCDs and NTDs. It
is known that poor quality care is a major contributor to
mortality in comparison to insufficient access and that for
chronic diseases complex multicomponent interventions are
need to address this gap [31]. Thus, there is an urgent need
to design and implement complex interventions that can im-
prove the access and quality of health care and close these
gaps [32, 33]. Complex interventions are needed to prevent
and/or manage NCDs and NTDs; some of these are at com-
munity, health systems and/or policy level and many add-
itional aspects needed to be considered (low literacy in the
population, overwhelmed services, low availability of medi-
cines) in order to have positive results. All these aspects
could affect the implementation of the intervention, and
process evaluation is key to understand the functioning of an
intervention in these diverse contexts [33].
Our discussion in the results paper will be enriched by
the contrast of our findings with those results from two
important studies found in the literature; one is the sys-
tematic review published by Liu et al. [4] that focuses on
process evaluation studies in NCDs, primary healthcare
and high-income countries identifying 69 articles, and
the second study was published by Scott et al. [34] which
explored the use of process evaluation in knowledge
translation research in 226 studies in English and inves-
tigated process evaluation design, data collection
Lazo-Porras et al. Systematic Reviews          (2021) 10:244 Page 5 of 7
methods and outcomes considered in the included
studies.
A few limitations need to be highlighted. All the lan-
guages could not be included due to human resource
constraints. It is possible that some articles will not be
identified by our search strategy even when studies not
labelled as process evaluations were included. Finally,
our search strategy will not be peer reviewed [35] but
will be designed with a librarian and it will be built
based on a previous systematic review [4].
In conclusion, given the increasing recognition of
process evaluations to provide evidence of interventions
that will address local contextual needs, this scoping re-
view will inform researchers and policymakers from two
perspectives: (i) identify attributes of process evaluations
and areas that need to be strengthened in order to con-
duct better process evaluation studies for NCDs and
NTDs in LMICs and (ii) inform future systematic re-
views in specific areas of process evaluation method-
ology and a nuance of the implementation of evidence-
based complex intervention in LMIC settings.
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